Palisade Bio Inc (PALI)

Mar 26, 2026

Palisade Bio (PALI) reports positive phase 1b data for PALI-2108 in UC patients - MSN

Mar 26, 2026

Mar 24, 2026

Big Picture: Can Palisade Bio Inc expand its profit marginsMarket Performance Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 24, 2026

Mar 23, 2026

PALI SEC FilingsPalisade Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 23, 2026

Mar 23, 2026

Palisade Bio: Undervalued Biotech With Blockbuster Potential, Initiating With A Speculative Buy Rating - Seeking Alpha

Mar 23, 2026

Mar 21, 2026

Aug Spikes: Can Palisade Bio Inc expand its profit marginsQuarterly Earnings Report & Weekly Return Optimization Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Palisade Bio 2026 10-K: Clinical Development, Risk Factors, and Precision Medicine Strategies for IBD - Minichart

Mar 20, 2026

Mar 20, 2026

Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

Palisade Bio (NASDAQ:PALI) Issues Quarterly Earnings Results, Beats Estimates By $1.10 EPS - MarketBeat

Mar 20, 2026

Mar 20, 2026

Palisade Bio Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 20, 2026

Mar 20, 2026

Palisade Bio 10-K: Net loss $16.8M, EPS $(0.30) - TradingView

Mar 20, 2026

Mar 20, 2026

[10-K] PALISADE BIO, INC. Files An... - Stock Titan

Mar 20, 2026

Mar 18, 2026

Palisade Bio (PALI) Reports Positive Phase 1b Data for PALI-2108 in UC Patients - Insider Monkey

Mar 18, 2026

Mar 18, 2026

PALI Q4'25 Earnings: revenue estimate is 0 USD - TradingView

Mar 18, 2026

Mar 17, 2026

Day Trade: Can Palisade Bio Inc beat the S P 500Bear Alert & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 17, 2026

Mar 16, 2026

Palisade Bio (PALI) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Mar 16, 2026

Mar 13, 2026

Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Mar 13, 2026

Mar 12, 2026

Palisade Bio (PALI) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 12, 2026

Mar 11, 2026

RSI Check: Will Palisade Bio Inc outperform its industry peers2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 07, 2026

Aug Macro: Can Palisade Bio Inc maintain sales growth2025 Buyback Activity & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Published on: 2026-03-07 13:46:23 - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

US Market Recap: Will Palisade Bio Inc stock recover after earningsTrade Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Treasury Yields: Will Palisade Bio Inc benefit from current market trends2025 Winners & Losers & Community Consensus Trade Signals - baoquankhu1.vn

Mar 05, 2026

Mar 04, 2026

Short Interest in Palisade Bio, Inc. (NASDAQ:PALI) Rises By 20.2% - MarketBeat

Mar 04, 2026

Mar 02, 2026

Palisade Bio Announces Participation in Two Upcoming Investor Conferences - Bitget

Mar 02, 2026

Mar 02, 2026

Investors get two chances to question Palisade Bio in March - Stock Titan

Mar 02, 2026

Mar 01, 2026

Palisade Bio Details PALI-2108 UC, Crohn’s Plans and Cash Runway Into 2029 at Oppenheimer Conference - MarketBeat

Mar 01, 2026

Feb 28, 2026

Palisade Bio (NASDAQ:PALI) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Feb 28, 2026

Feb 28, 2026

Palisade Bio (NASDAQ:PALI) Upgraded to “Hold” at Wall Street Zen - Defense World

Feb 28, 2026

Feb 28, 2026

PALI Should I Buy - Intellectia AI

Feb 28, 2026

Feb 26, 2026

PALI: Advancing a once-daily, gut-restricted PDE4 inhibitor with strong funding and pivotal trials ahead - TradingView

Feb 26, 2026

Feb 25, 2026

Palisade Bio (NASDAQ:PALI) Now Covered by Stifel Nicolaus - MarketBeat

Feb 25, 2026

Feb 25, 2026

Stifel Initiates Palisade Bio at Buy With $5 Price Target - marketscreener.com

Feb 25, 2026

Feb 25, 2026

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Feb 25, 2026

Feb 25, 2026

Palisade Bio (PALI) Sees New 'Buy' Rating from Stifel | PALI Sto - GuruFocus

Feb 25, 2026

Feb 25, 2026

Stifel Initiates Coverage of Palisade Bio (PALI) with Buy Recommendation - Nasdaq

Feb 25, 2026

Feb 25, 2026

Stifel initiates Palisade Bio stock with buy rating on IBD drug - Investing.com India

Feb 25, 2026

Feb 24, 2026

PALI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 24, 2026

Stifel initiates Palisade Bio stock with buy rating on IBD drug By Investing.com - Investing.com Canada

Feb 24, 2026

Feb 24, 2026

Palisade Bio Strengthens Advisory Board, Fast-tracks Key Research Developments - timothysykes.com

Feb 24, 2026

Feb 24, 2026

Palisade Bio presents ulcerative colitis drug trial data at ECCO By Investing.com - Investing.com India

Feb 24, 2026

Feb 23, 2026

Palisade Bio presents ulcerative colitis drug trial data at ECCO - Investing.com

Feb 23, 2026

Feb 23, 2026

Palisade Bio, Inc. Presents Phase 1b Data Demonstrating Localized Target Engagement and Early Clinical Response of PALI-2108 in Ulcerative Colitis at ECCO 2026 - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026 - Bitget

Feb 23, 2026

Feb 23, 2026

Palisade Bio Reports Rapid Clinical, Histologic and New - GlobeNewswire

Feb 23, 2026

Feb 20, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2026

Feb 19, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Sees Large Increase in Short Interest - Defense World

Feb 19, 2026

Feb 17, 2026

Palisade Bio appoints IBD expert to clinical advisory board By Investing.com - Investing.com Canada

Feb 17, 2026

Feb 17, 2026

Perceptive fund discloses 9.99% Palisade Bio (PALI) ownership stake - Stock Titan

Feb 17, 2026